Dose-Reduced Trastuzumab Emtansine: Active and Safe in Acute Hepatic Dysfunction

por Sharp, Adam, Johnston, Stephen R.D.
Publicado 2015

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

por Pegram, Mark, Jackisch, Christian, Johnston, Stephen R. D.
Publicado 2023

Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer

por Angelis, Vasileios, Johnston, Stephen R. D., Ardestani, Amin, Maedler, Kathrin
Publicado 2022

97P Is continuing CDK4-6 inhibitor therapy safe during the COVID-19 pandemic? A UK cancer centre experience

por Angelis, V., McFarlane, P., Cunningham, N., Gennatas, S., Johnston, S.R.D., Okines, A., McGrath, S.
Publicado 2021

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer

por Gibbs, D D, Pyle, L, Allen, M, Vaughan, M, Webb, A, Johnston, S R D, Gore, M E
Publicado 2002

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK expe...

por Sutherland, S, Ashley, S, Miles, D, Chan, S, Wardley, A, Davidson, N, Bhatti, R, Shehata, M, Nouras, H, Camburn, T, Johnston, S R D
Publicado 2010

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer

por Urruticoechea, A, Archer, C D, Assersohn, L A, Gregory, R K, Verrill, M, Mendes, R, Walsh, G, Smith, I E, Johnston, S R D
Publicado 2005

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

por Eisen, T, Boshoff, C, Mak, I, Sapunar, F, Vaughan, M M, Pyle, L, Johnston, S R D, Ahern, R, Smith, I E, Gore, M E
Publicado 2000

Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives

por Lother, Dione, Robert, Marie, Elwood, Elliot, Smith, Sam, Tunariu, Nina, Johnston, Stephen R.D., Parton, Marina, Bhaludin, Basrull, Millard, Thomas, Downey, Kate, Sharma, Bhupinder
Publicado 2023

Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1

por Toi, Masakazu, Boyle, Frances, Im, Young-Hyuck, Reinisch, Mattea, Molthrop, David, Jiang, Zefei, Wei, Ran, Sapunar, Francisco, Grimes, Brenda R, Nabinger, Sarah Cassidy, Johnston, Stephen R D
Publicado 2022

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

por Cristofanilli, Massimo, Johnston, Stephen R. D., Manikhas, Alexey, Gomez, Henry L., Gladkov, Oleg, Shao, Zhimin, Safina, Sufia, Blackwell, Kimberly L., Alvarez, Ricardo H., Rubin, Stephen D., Ranganathan, Sulabha, Redhu, Suman, Trudeau, Maureen E.
Publicado 2012

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breas...

por Paluch-Shimon, Shani, Neven, Patrick, Huober, Jens, Cicin, Irfan, Goetz, Matthew P., Shimizu, Chikako, Huang, Chiun-Sheng, Lueck, Hans Joachim, Beith, Jane, Tokunaga, Eriko, Contreras, Jessica Reyes, de Sant’Ana, Rosane Oliveira, Wei, Ran, Shahir, Ashwin, Nabinger, Sarah C., Forrester, Tammy, Johnston, Stephen R. D., Harbeck, Nadia
Publicado 2023

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the mona...

por Martin, Miguel, Hegg, Roberto, Kim, Sung-Bae, Schenker, Michael, Grecea, Daniela, Garcia-Saenz, Jose Angel, Papazisis, Konstantinos, Ouyang, QuChang, Lacko, Aleksandra, Oksuzoglu, Berna, Reeves, James, Okera, Meena, Testa, Laura, Shimizu, Chikako, Denduluri, Neelima, Adamchuk, Hryhoriy, Dakhil, Shaker, Wei, Ran, Forrester, Tammy, Fernandez, Maria Munoz, Zimmermann, Annamaria, Headley, Desiree, Johnston, Stephen R. D.
Publicado 2022

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

por Johnston, Stephen R. D., Harbeck, Nadia, Hegg, Roberto, Toi, Masakazu, Martin, Miguel, Shao, Zhi Min, Zhang, Qing Yuan, Martinez Rodriguez, Jorge Luis, Campone, Mario, Hamilton, Erika, Sohn, Joohyuk, Guarneri, Valentina, Okada, Morihito, Boyle, Frances, Neven, Patrick, Cortés, Javier, Huober, Jens, Wardley, Andrew, Tolaney, Sara M., Cicin, Irfan, Smith, Ian C., Frenzel, Martin, Headley, Desirée, Wei, Ran, San Antonio, Belen, Hulstijn, Maarten, Cox, Joanne, O’Shaughnessy, Joyce, Rastogi, Priya
Publicado 2020

Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

por Lindsay, Colin R, Shaw, Emily C, Blackhall, Fiona, Blyth, Kevin G, Brenton, James D, Chaturvedi, Anshuman, Clarke, Noel, Dick, Craig, Evans, Thomas R J, Hall, Geoff, Hanby, Andrew M, Harrison, David J, Johnston, Stephen R D, Mason, Malcolm D, Morton, Dion, Newton-Bishop, Julia, Nicholson, Andrew G, Oien, Karin A, Popat, Sanjay, Rassl, Doris, Sharpe, Rowena, Taniere, Phillipe, Walker, Ian, Wallace, William A, West, Nicholas P, Butler, Rachel, Gonzalez de Castro, David, Griffiths, Mike, Johnson, Peter W M
Publicado 2018